Publication: Anti-inflammatory and antifibrotic
effects of resveratrol in the lung
Authors
Conte, Enrico ; Fagone, Evelina ; Fruciano, Mary ; Gili, Elisa ; Iemmolo, Maria ; Vancheri, Carlo
item.page.secondaryauthor
item.page.director
Publisher
F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-30.523
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Resveratrol, a natural polyphenolic molecule
with several biological activities, is a well recognized
anti-oxidant, anti-aging and cancer chemopreventive
agent. Moreover, resveratrol anti-inflammatory and
antifibrotic properties have been demonstrated both in
vitro and in different animal models of inflammatory
pathologies, including bowel and liver diseases. We
review the evidence of resveratrol protective role in
respiratory diseases such as acute lung injury, asthma,
chronic obstructive pulmonary disease and lung fibrosis.
We conclude that resveratrol and its derivatives may act
as a therapeutic agents in respiratory diseases and
pertinent clinical trials should be performed.
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. CC BY 4.0